Anand Rayons IPO vs Par Drugs IPO

Comparison between Anand Rayons IPO and Par Drugs IPO.

IPO Details

Anand Rayons IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Anand Rayons IPO is up to ₹12.01 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Anand Rayons IPO is ₹27.00 per share and of Par Drugs IPO is ₹51.00 per share.

 Anand Rayons IPOPar Drugs IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹27.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size4000 shares2000 shares
Fresh Issue Size44,48,000 shares15,88,000 shares
Fresh Issue Size (Amount)up to ₹12.01 Crup to ₹8.10 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total44,48,000 shares15,88,000 shares
Issue Size Total (Amount)up to ₹12.01 Crup to ₹8.10 Cr

IPO Timetable

Anand Rayons IPO opens on Jun 18, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Anand Rayons IPO and Par Drugs IPO is Jun 24, 2019, and May 08, 2019, respectively.

 Anand Rayons IPOPar Drugs IPO
Issue OpenJun 18, 2019May 03, 2019
Issue CloseJun 24, 2019May 08, 2019
Basis Of Allotment (Tentative)Jun 27, 2019May 13, 2019
Initiation of Refunds (Tentative)Jun 28, 2019May 14, 2019
Credit of Share (Tentative)Jul 01, 2019May 15, 2019
Listing date (Tentative)Jul 02, 2019May 16, 2019

Financials & KPIs

Anand Rayons IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .

 Anand Rayons IPOPar Drugs IPO
Financials

Company Financials (Restated)

Period Ended31 Jan 201931 Mar 201831 Mar 201731 Mar 2016
Assets61.0359.4258.0937.96
Total Income231.76259.59270.62219.92
Profit After Tax1.721.451.050.46
EBITDA5.226.575.203.09
NET Worth13.478.726.665.36
Reserves and Surplus3.181.45
Total Borrowing28.2532.6630.1423.17
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets51.3653.9456.04
Total Income46.4142.4248.81
Profit After Tax2.421.501.85
EBITDA5.288.028.50
NET Worth29.1220.7019.20
Reserves and Surplus24.6412.2510.75
Total Borrowing11.5823.1324.81
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%99.55%
Promoter Shareholding (Post-Issue)68.71%72.5%
Market Cap₹40.46 Cr.₹31.38 Cr.

Shares Offered

In the Anand Rayons IPO Retail Individual Investors (RII) are offered 22,24,000 shares while in Par Drugs IPO retail investors are offered 22,24,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Anand Rayons IPO and in Par Drugs IPO.

 Anand Rayons IPOPar Drugs IPO
Anchor Investor Reservation0 shares
Market Maker Reservation2,40,000 shares84,000 shares
QIB0 shares
NII22,24,000 shares7,78,000 shares
RII22,24,000 shares7,80,000 shares
Employee0 shares30,000 shares
Total44,48,000 shares15,88,000 shares

Bids Received (Subscription)

Anand Rayons IPO subscribed 1.17x in total, whereas Par Drugs IPO subscribed 5.64x.

 Anand Rayons IPOPar Drugs IPO
NII (times)1.86x3.48x
RII (times)0.48x7.97x
Employee (times)1.00x
Total (times)1.17x5.64x

Compare with others

Compare:

Anand Rayons IPO Vs Par Drugs IPO